Table 1.
Product | Compounds | Study Type | Subjects/ Cell Lines |
Main Effects | Possible Mechanisms | Ref. |
---|---|---|---|---|---|---|
Antioxidant Activity | ||||||
Aged garlic extract | In vitro | Human endothelial cells | Protecting cells against oxidative stress | Inducing the expression of several antioxidant enzymes, HO-1 and GCLM subunit, through Nrf2- ARE pathway | [43] | |
Saponins | In vitro | Mouse-derived C2C12 myoblasts | Protecting cells against the growth inhibition and DNA damage induced by H2O2 | Scavenging intracellular reactive oxygen species | [44] | |
Anti-inflammatory Activity | ||||||
Ethyl linoleate | In vitro | Lipopolysaccharide-stimulated RAW 264.7 macrophages | Reducing the production of NO and prostaglandin E-2 | Down regulating the expression of iNOS and COX2 | [45] | |
Garlic 14-kDa protein | In vitro | Lipopolysaccharide-stimulated J774A.1 macrophages | Inhibiting the inflammatory mediators such as NO, TNF-α, and IL-1β | Inhibiting the transcription factor NF-κB signaling pathway | [46] | |
Aged garlic extract | In vivo | Apolipoprotein E-knockout mice | Inhibiting inflammation | Reducing the level of TNF-α and interleukin IL-1 receptor-associated kinase 4 Increasing the activity of AMPK in the liver |
[47] | |
Allicin | In vivo | BALB/c mice | Protecting against the inflammatory response induced by schistosome infection | [48] | ||
Garlic tablets (equal to 2.5 g fresh garlic daily) | Clinical trial | 40 post-menopausal obese or overweight patients | Alleviating osteoarthritis | Reducing resistin | [49] | |
Antimicrobial Activity | ||||||
Garlic “Rosato” and “Caposele” | In vitro | Aspergillus versicolor, Penicillum citrinum and Penicillium expansum | Inhibiting the growth of bacteria | [53] | ||
Aged garlic extract | Allicin | In vitro | Burkholderia cepacian | Inhibiting the growth of bacteria | [54] | |
Garlic oil | In vitro | Staphylococcus aureus, Escherichia coli and Bacillus subtilis | Inhibiting the growth of bacteria | [50] | ||
In vitro | Penicillium funiculosum | Inhibiting the growth of bacteria | Penetrating into cells and organelles Destroying the cell structure Leading to the leakage of cytoplasm and macromolecules |
[55] | ||
In vitro | Candida albicans | Disrupting the normal metabolism of bacteria | Inducing key genes involved in oxidative phosphorylation, the cell cycle, and protein processing in the endoplasmic reticulum | [56] | ||
Raw garlic | Clinical trial | 15 patients with H. pylori infection | Inhibiting Helicobacter pylori in the stomach | [57] | ||
Modulating Immune System | ||||||
Fresh garlic | Polysaccharides/ Fructan |
In vitro | RAW 264.7 macrophages | Exerting immunomodulatory effect | Regulating the expressions of IL-6, IL-10, TNF-α, and interferon-γ | [58] |
Garlic oil | In vivo | Wistar rats | Normalizing several immunological parameters of rats, such as the serum total immunoglobulin concentration and T-cell subtype CD4+ Combination of garlic oil and levamisole could balance the T-helper 1/ T-helper 2 response |
[59,60] | ||
Selenizing garlic polysaccharides | In vivo | 14-day-old chickens | Promoting lymphocyte proliferation Enhancing interferon-γ and IL-2 Increase the serum antibody titer |
[61] | ||
Aged garlic extract | Clinical trial | 56 healthy human participants | Reducing the occurrence and severity of cold and flu Improving the immune system functions |
[8] | ||
Cardiovascular Protection | ||||||
Aged garlic extract | In vitro | Isolated rat aortic rings | Leading to endothelial-dependent vasodilation | Stimulating the production of NO | [71] | |
Aged black garlic extract | Polyphenols | In vivo | Isolated hearts of male Sprague–Dawley rats | Relaxing coronary arteries before and after ischemia-reperfusion in rat Preventing the decrease of myocardial contractility |
[90] | |
Aged garlic extract | S-1-propylenecysteine | In vivo | Spontaneous hypertension rats | Improving peripheral blood circulation Reducing the systolic blood pressure |
[75] | |
Fermented garlic extract by Bacillus subtilis | In vivo | Spontaneous hypertension rats | Reducing the systolic blood pressure | Modulating the sGC-cGMP-PKG pathway | [76] | |
Fermented garlic extract | In vivo | Monocrotaline-induced pulmonary hypertension rats | Alleviating pulmonary hypertension | Decreasing the expression of vascular endothelial cell adhesion molecule-1 and MMP- 9Increasing the expression of PKG and eNOS |
[77] | |
Garlic | Alliin | In vivo | Female Wistar albino rats | Increasing the activity of captopril on inhibiting ACE and hypertension | [72] | |
1.5% black garlic extract | In vivo | High-fat diet-fed male Sprague–Dawley rats | Modulating the metabolism of lipid and cholesterol Decreasing the levels of blood total lipids, triglyceride, and cholesterol |
Reducing the mRNA expression of sterol regulatory element binding protein-1c | [80] | |
Raw garlic | Allyl methyl sulfide/Allyl methyl sulfoxide | In vivo | Male Sprague–Dawley rats | Reduce cardiac hypertrophy remodeling induced by isoproterenol | Increasing Na+/K+-ATPase protein level | [83] |
Raw garlic | In vivo | Streptomycin-induced diabetic rats | Protecting the heart function Activating sirtuin 3-manganese superoxide dismutase pathway |
Deacetylating manganese superoxide dismutase | [84] | |
Garlic extract | In vivo | Insulin-resistant obese rats | Protecting heart rate variability, cardiac dysfunction, and mitochondrial dysfunction | [86] | ||
In vivo | Rat model of gentamicin-induced chronic renal failure | Protecting the heart tissue | Reducing oxidative stress Controlling Na+/K+-ATPase activity and Ca2+ levels |
[87] | ||
Aged garlic extract | SAC | In vivo | Rats with myocardial dysfunction induced by isoproterenol | Protecting against cardiotoxicity | [88] | |
Aged garlic extract | In vivo | Apolipoprotein E-knockout mice | Inhibiting inflammatory response to prevent atherosclerosis | Reducing serum level of C-reactive protein and thromboxane B-2, protein level of TNF-α and IL-1 receptor-associated kinase 4 Increasing AMPK activity in the liver |
[47] | |
In vivo | Apolipoprotein E-knockout mice | Inhibiting the vascular inflammation and lipid deposition in the early stage of atherosclerosis development | [91] | |||
High temperature and high pressure-processed garlic | In vivo | High-cholesterol diet-fed Sprague–Dawley rats | Reducing the levels of total cholesterol, low-density lipoprotein cholesterol and triglyceride | [79] | ||
Garlic | Cohort study | 30 patients with diabetic dyslipidemia | Decreasing the level of cholesterol and low-density lipoprotein Increase the level of high-density lipoprotein |
[81] | ||
Aged garlic | Clinical trial | 41 patients with hypercholesterolemia | Reducing the activity of myeloperoxidase and lipid hydroperoxide in serum Decreasing the concentration of F2-isoprostanes in plasma and urine | [82] | ||
Enzymatic browning processed garlic | Clinical trial | 44 patients with hypertension | Reducing systolic blood pressure and diastolic blood pressure | [78] | ||
Anticancer Activity | ||||||
Garlic extract | In vitro | Bladder cancer EJ cells | Inducing G2/M-phase cell cycle arrest Inhibiting cell growth Inhibiting cell migration and invasion |
Activating the ATM pathway and CHK2; Inhibiting the expression of MMP-9 Reducing the binding activity of transcription factors AP-1, specificity protein-1 and NF-κB motifs Increasing the expression of heat shock protein A6 |
[113] | |
Aged garlic extract | In vitro | Colorectal cancer cell lines (SW480 and SW620) ECV304 cells and the transformed rat lung endothelial cells |
Decreasing invasive activity Inhibiting cell proliferation Decreasing invasive activity Inhibiting the tube formation of endothelial cells |
Inhibiting cell motility | [124] | |
In vitro | DLD-1 human colon cancer cells (ATCC CCL-221) | Inhibiting cell proliferation | Down regulating the expression of cyclin B1 and CDK1 Inhibiting of activation of NF-κB |
[121] | ||
Crude garlic extract | Lipid bioactive compounds | In vitro | Human liver cancer (Hep-G2) Colon cancer (Caco-2) Prostate cancer (PC-3) Breast cancer (MCF-7) Mouse macrophage cell (TIB-71) lines |
Inhibiting the growth rate of Hep-G2, PC-3, MCF-7, and TIB-71 cells by 80%–90% at 72 h (P < 0.05). | Inhibiting cell proliferation Inducing cell cycle arrest Inducing apoptosis |
[112] |
Allicin | In vitro | Human gastric adenocarcinoma cell line | Inhibiting cell proliferation | Inducing cell cycle arrest at S-phase | [18] | |
DATS | In vitro | Human gastric carcinoma cell line (SGC-7901) | Inhibiting cell proliferation Blocking cell cycle Increasing apoptotic cell death |
Accumulating Bax, p53, and cytochrome C and decreasing the expression of Bcl-2 | [114] | |
In vitro | Human breast cancer cell line (MDA-MB-231) | Inhibiting angiogenesis | [125] | |||
Z-ajoene | In vitro | Glioblastoma multiforme cells | Inhibiting the growth of the cancer stem cells population | [119] | ||
In vitro | Human breast cancer cells (MDA-MB-231) | Inhibiting cell growth Inducing cell apoptosis |
Targeting the folding of proteins in the endoplasmic reticulum of cancer cells | [120] | ||
SAC | In vitro | Human epithelial ovarian cancer cell line (A2780) | Inhibiting cell proliferation Inducing G1/S-phase cell cycle arrest Increasing apoptosis Reducing the migration of cells |
Decreasing the expression of pro-caspase-3, Parp-1 Bcl-2 and increasing active caspase-3 and Bax Reducing the expression of Wnt5a, phosphorylation protein kinase B and c-Jun proteins |
[115] | |
SPRC | In vitro | Human pancreatic ductal adenocarcinoma cells (Panc-1) | Inhibiting cell proliferation Inducing apoptosis |
Inducing G2/M-phase cell cycle arrest Regulating the level of JNK protein |
[116] | |
SAMC | In vitro | Human colorectal carcinoma cell line (SW620) | Inhibiting cell proliferation Inducing cell apoptosis |
Regulating JNK and p38 MAPK pathways | [118] | |
In vitro | Hepatoma cell lines (Hep3B and Huh-7) | Reducing the cell viability Shortening the S phase and increasing the G0/G1 phase |
[117] | |||
Alliin | In vitro | Gastric adenocarcinoma cells | Regulating cell apoptosis | Generating reactive oxygen species Decreasing mitochondrial membrane potential by Bax/Bcl-2 Up-regulating cytochrome C |
[18] | |
Aged garlic extract | In vivo | Adult male Wister albino rats treated with cisplatin | Improving the renal histological, ultrastructural and biochemical changes, such as hemorrhage, glomerular atrophy, tubular necrosis and degeneration | [128] | ||
In vivo | Fibrosarcoma tumors implanted BALB/c mice | Improving the immune responses of mice to fibrosarcoma Inhibiting tumor growth |
Increasing the ratio of CD4+/CD8+ Producing interferon-γ in splenocytes |
[131] | ||
Garlic and lemon aqueous extract | In vivo | BALB/c mice xenograft model of breast cancer EMT6/P cells | Reducing tumor size Inhibiting angiogenesis Inducing apoptosis Activating the immune system |
Inhibiting the expression of vascular endothelial growth factor Increasing interferon-γ, IL-2, and IL-4 levels |
[126] | |
Allicin | In vivo | Female Swiss albino mice | Alleviating liver injury induced by tamoxifen | Changing the decrease of superoxide dismutase, glutathione and total protein and the increase of aspartate aminotransferase, alkaline phosphatase and alanine aminotransferase levels | [129] | |
DADS | In vivo | FVB/N mice | Preventing colorectal tumorigenesis induced by azoxymethane and dextran sulfate | Inhibiting inflammation Inhibiting glycogen-synthase kinase-3β Reducing the nuclear localization of NF-κB |
[132] | |
DATS | In vivo | Female BALB/c-nude mouse xenograft model of human gastric carcinoma SGC-7901 cells | Inhibiting tumor growth Promoting tumor apoptosis |
Regulating the expressions of MMP-9 and E-cadherin protein | [114] | |
SPRC | In vivo | Xenograft model of pancreatic ductal adenocarcinoma Panc-1 cells | Inhibiting tumor growth | Regulating the level of JNK protein | [116] | |
SAMC | In vivo | Mouse xenograft model of hepatoma Huh-7 cells | Inhibiting tumor growth | Interacting with the Wnt-pathway co-receptor LRP6 on the cell membrane | [117] | |
Raw, crushed garlic | Cohort study | 17 volunteers from Beltsville, Maryland | Up-regulating seven genes including AHR, ARNT, HIF1A, JUN, NFAM1, OSM and REL | [123] | ||
Garlic extract | Cohort study | Patients who received chemotherapy for hematological malignancies | Protective effect on febrile neutropenia in lower-risk subgroup | [130] | ||
Hepatoprotective Activity | ||||||
Black garlic extract | In vitro | Rat clone-9 hepatocytes | Inhibiting apoptosis, lipid peroxidation, oxidative stress, and inflammation | [136] | ||
Garlic extract | In vivo | Wistar rats | Attenuating the liver damage induced by alloxan Improving plasma biochemical factors of hepatic function, such as urea, creatinine, aspartate transaminase, and alanine transaminase |
[137] | ||
Single clove garlic extract | In vivo | Male rabbits | Protecting against CCl4-induced acute liver injury | [38] | ||
LAFGE | In vivo | C57/BL6 J mice | Reducing the liver lipid level Ameliorating the hepatic steatosis |
[142] | ||
In vivo | rats | Inhibiting liver cell apoptosis Protecting liver from acetaminophen-induced liver injury |
Suppressing MAPK phosphorylation Down regulating p53 |
[143] | ||
Garlic oil | In vivo | 1,3-Dichloro-2-propanol-treated rats | Protecting liver | Enhancing the activities of hepatic antioxidant enzymes Blocking metabolic activation of 1, 3-dichloro-2-propanol Reducing the apoptosis in liver |
[139] | |
DADS | In vivo | Wistar rats | Protecting mice from nonalcoholic fatty liver disease induced by long-term high-fat diet. | Reducing the release of pro-inflammatory cytokines in the liver Increasing antioxidant activity by inhibiting the expression of cytochrome P450 2E1 |
[141] | |
LAFGE | Clinical trial | 36 adults with mildly high level of serum gamamyl glutamyl transpeptiase | Improving the levels of gamamyl glutamyl transpeptias and alanine aminotransferase without adverse effects | [144] | ||
Digestive System Protection | ||||||
Black garlic extract | In vitro | Small intestine | Stimulating gastrointestinal peristalsis Promoting gastrointestinal emptying and facilitates defecation. |
[146] | ||
DADS DAS |
In vitro | Interferon-γ-stimulated intestinal cells | Reducing interferon-inducible protein-10, IL-6 Inhibiting NO and the expression of STAT-1 |
[70] | ||
In vivo | Male ICR mice | Improving the colitis induced by dinitrobenzenesulfonic acid | [70] | |||
Garlic and cabbage extract | In vivo | Sprague–Dawley rats | Reducing the length of gastric ulcer, the total gastric acid, gastric juice volume, total bacteria count, and histopathological changes caused by aspirin Improving the pH value of gastric juice |
[147] | ||
Aged garlic extract | In vivo | Male albino rats | Healing the gastric mucosal injury induced by indomethacin Reducing the total microbial amount in stomach |
[148] | ||
In vivo | Male Wistar rats | Preventing the indomethacin-induced ulcer | Reducing oxidative stress Elevating the level of prostaglandin E-2, glutathione, and NO in gastric tissue |
[149] | ||
Allicin | In vivo | Dextran sulfate sodium-induced colitis mice | Alleviating the ulcerative colitis induced by dextran sulfate sodium | Inhibiting the activation of AP-1/NF-κB/signal transducer and activator of transcription-1 Inhibiting the phosphorylation of p38, JNK, and extracellular signal-regulated kinase 1/2 -regulated PPAR-γ | [150] | |
Raw garlic | Clinical trial | 15 patients with H. pylori infection | Decreasing the bacterial urease activity Reducing the residing of Helicobacter pylori in the stomach | [57] | ||
Anti-Diabetic Activity | ||||||
Garlic | In vivo | Diabetic rats | Protecting against diabetic retinopathy Improving weight, blood glucose, and morphological changes of retinal tissue | [152] | ||
Clinical trial | 768 patients with type 2 diabetes mellitus | Reducing fructosamine and glycosylated hemoglobin | [154] | |||
Anti-Obesity Activity | ||||||
LAFGE | In vivo | High-fat diet-fed male C57BL/6J mice | Reducing the weight Reducing the epididymal, retroperitoneal, and mesenteric adipose tissue mass |
Inhibiting the lipogenesis by down-regulating the mRNA and protein expression of PPAR-γ, C/EBPα, and lipogenic proteins | [9] | |
Methanolic extract of black garlic | In vivo | High-fat diet-fed male Wistar rats | Reducing the weight Regulating lipid metabolism |
Upregulating the expression of AMPK, forkhead box protein O1, perilipin, and adiponectin in the adipose tissue Down-regulating cluster of differentiation 36, plasminogen activator inhibitor 1, resistin, and TNF-α |
[156] | |
Garlic oil | In vivo | High-fat diet-fed male Sprague–Dawley rats | Counteracting the influence of high-fat diet on the body weight and adipose tissue weight | [155] | ||
Neuroprotection | ||||||
Aged garlic extract | FruArg | In vitro | Lipopolysaccharide-activated murine BV-2 microglial cells | Alleviating neuroinflammation | Inhibiting the production of NO Regulating the expression of multiple protein targets related to oxidative stress |
[157] |
Garlic extract | In vivo | Female Wistar rats | Reducing the concentration of Pb in the blood and brain Preventing the Pb-induced apoptosis of neurons |
[159] | ||
Aged garlic extract | In vivo | Adult male Wistar rats | Attenuating the damage of working memory | Improving the loss of cholinergic neurons Increasing the level of vesicular glutamate transporter 1 and glutamate decarboxylase in the hippocampal area |
[161] | |
Ethanol extract of garlic | In vivo | Diabetic Wistar rats | Improving memory | Increasing the activity of Na+/K+ ATPase, Ca2+ ATPase, and glutamine synthetase in the hippocampus | [162] | |
Z-ajoene | In vivo | Male gerbils | Preventing I/R-induced delayed neuronal death and gliosis region of the hippocampus |
Reducing lipid peroxidation in the CA1 | [15] | |
SAC | In vivo | Male albino Wistar rats | Ameliorating the cognitive impairment | Reducing oxidative stress, neuroinflammation, astrogliosis, and acetylcholinesterase activity | [164] | |
Renal Protection | ||||||
Aqueous extract of garlic | In vivo | Type 1 diabetic rats | Reducing the oxidative stress in the kidneys | [165] | ||
In vivo | Wistar rats | Improving the renal plasma biochemical factors induced by alloxan | [137] | |||
DATS | In vivo | Male albino rats | Protecting the kidney from oxidative stress injury induced by As | Activating the Nrf2-ARE pathway | [166] |
Abbreviations: ACE, angiotensin-converting enzyme; AHR, aryl hydrocarbon receptor; allicin, diallyl thiosulfonate; alliin, S-allyl-cysteine sulfoxide; AMPK, adenosine monophosphate-activated protein kinase; AP-1, activator protein 1; ARE, antioxidant response element; ARNT, aryl hydrocarbon receptor nuclear translocator; ATM, ataxia-telangiectasia mutated; Bax, Bcl-2 associated X; Bcl-2, B cell lymphoma-2; CDK1, cyclin-dependent kinase 1; cGMP, cyclic guanosine monophosphate; CHK2, checkpoint kinase 2; COX2, cyclooxygenase-2; DADS, diallyl disulfide; DAS, diallyl sulfide; DATS, diallyl trisulfide; eNOS, endothelial nitric oxide synthase; FruArg, N-α-(1-deoxy-D-fructos-1-yl)-l-arginine; GCLM, glutamate-cysteine ligase modifier; HIF1A, hypoxia-inducible factor 1α; HO-1, heme oxygenase-1; IL, interleukin; iNOS, inducible NO synthase; JNK, Jun N-terminal kinase; JUN, proto-oncogene c-Jun; LAFGE, fermented garlic extract by Lactobacillus plantarum BL2; MMP-9, matrix metalloproteinase-9; NFAM1, nuclear factor of activated T cells (NFAT) activating protein with immunoreceptor tyrosine-based activation motif 1; NF-κB, nuclear factor-kappa B; NO, nitric oxide; Nrf2, nuclear factor erythrobia-2 related factor 2; OSM, oncostatin M; Parp-1, poly (ADP-ribose) polymerase-1; PKG, protein kinases G; PPAR-γ, peroxisome proliferator-activated receptor-γ; p38 MAPK, p38 mitogen activated protein kinase; REL, V-relavian reticuloendotheliosis viral oncogene homolog; SAC, S-allyl-cysteine; sGC, soluble guanylyl cyclase; SAMC, S-allylmercaptocysteine; SPRC, S-propargyl-l-cysteine; STAT-1, signal transducer and activator of transcription-1; TNF-α, tumor necrosis factor-α; Wnt5a, wingless-type MMTV integration site family member 5A.